No abstract available
MeSH terms
-
Antitubercular Agents / administration & dosage
-
Female
-
Humans
-
Incidence
-
Kidney Failure, Chronic / therapy
-
Male
-
Monitoring, Physiologic
-
Peritoneal Dialysis, Continuous Ambulatory / adverse effects*
-
Peritonitis, Tuberculous / drug therapy
-
Peritonitis, Tuberculous / epidemiology
-
Peritonitis, Tuberculous / etiology*
-
Prognosis
-
Risk Factors